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Objectives: To evaluate the effectiveness of Toki’s criteria in identifying the HPV L1 protein in oral lesions with the 
use of immunohistochemistry (IHC) and to determine which criteria optimize such identification. 
Study Design: Retrospective study of 277 cases diagnosed as HPV lesions at 22 years. Tests of sensitivity, specificity, 
positive predictive value (PPV), negative predictive value (NPV), kappa coefficients, and chi2 values, as well as two 
logistic regression analyses (p≤0.05), were conducted. 
Results: Of the lesions studied, 96.4% (267 of 277) were positive for HPV using Toki’s criteria and 28.5% (79 of 
277) were positive for L1 by IHC. Toki’s criteria showed sensitivity=93.67%, specificity=2.53%, PPV=6.99%, and 
NPV=46.55%. Neither concordance nor statistically significant associations were observed between both tests. The 
logistic regression of Toki’s criteria was useful in the diagnosis of L1, correctly classified 71.8% of the lesions posi-
tive for L1, and showed a Hosmer-Lemeshow adjustment of p=0.614 and a Nagelkerke’s coefficient of determination 
of 6.8%. The explanatory variables statistically significant at p≤0.05 were dyskeratosis (p=0.01) and papillomatosis 
(p=0.04). Forty-nine independent variables (clinical and histopathologic) were involved in the second regression 
analysis. The model correctly classified 85.2% of the lesions and showed a Hosmer-Lemeshow adjustment of p=0.696 
and a Nagelkerke’s coefficient of determination of 60.2%. The explanatory variables statistically significant at p≤0.05 
were: age younger than 35 years (p=0.001), multiple lesions (p=0.031), hyperorthokeratosis (p=0.019), focal intra-
cellular edema (p=0.002), and the presence of 1 to more than 5 cells with degenerative changes in their nucleus 
(p=0.048). 
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Conclusions: Toki’s criteria are not adequate to make a diagnosis of lesions by HPV in the mouth, but the logistic 
regression analysis showed clinical and histopathologic variables which optimize the identification of lesions through 
the L1 protein. However, a PCR study is advisable when the presence of high-risk HPV is suspected. 
Key words: HPV, Toki’s criteria.
Introduction
The human papillomavirus (HPV) is a member of the 
papillomaviridae family (1), which can infect the oral 
mucosa of adults and children by different modes of 
transmission (2,3). This infection takes place in the cells 
of the basal layer and over a variable incubation period 
of up to 20 years, which may culminate in a latent, sub-
clinical, or clinical infection where benign, potentially 
malignant, or malignant lesions can become evident 
(4).
In 1987, Toki defined the use of a scoring system called 
“HPV score” for detecting HPV in cervical lesions. The 
system consists of giving a score on six histologic find-
ings: koilocytosis, 4; bi- and multinucleation, 2; dysk-
eratosis, 1; intraepithelial capillary loops (papillomato-
sis), 1; basal cell hyperplasia, 1; and acanthosis, 1. The 
maximum score using this system is 10 points, and a 
diagnosis of HPV is declared when a score of over 6 
points is achieved (5). However, the molecular behavior 
of the virus in the mouth is different from that in the 
cervix and as subclinical as clinical infection independ-
ently of their type can present its genome as episomal, 
integrated, or both (6), even in events of oral carcinoma 
(OC) (7).
The HPV contains 7,200 to 8,000bp in a circular dou-
ble-stranded DNA molecule covered by a capsid of pro-
teins of icosahedral form with 72 capsomeres (6). Their 
DNA encodes eight open reading frames (ORFs), six 
early (E) ORFs (E1, E2, E4, E5, E6, and E7) that en-
code nonstructural regulatory proteins, and two late (L) 
ORFs (L1 and L2) that encode proteins for the capsid. 
In addition, the HPV genomes have a region called the 
upstream regulatory region (URR); this is located be-
tween the early and late regions and includes the origin 
of the replication, the E6/E7 promoter gene, enhancers, 
and silencers (6).
The expression of early genes occurs throughout all 
epithelial layers (4). The E1 and E2 proteins surround 
the origin of the viral replication and are responsible for 
maintaining the viral DNA as episomes. In particular, 
E2 has the ability to suppress the activity of the E6 and 
E7 promoters (8).
In infections of high risk, the integration of the viral 
DNA into the cell genome alters the E2 ORF, which 
causes the loss of the repressive function of the E2 pro-
tein, increasing the expression of the E6 and E7 onco-
proteins (8). This facilitates the cell-to-cell replication 
of the DNA virus and the decrease in the expression 
of L1 (9). On the other hand, in infections of low risk, 
the E1 protein recruits the cell elements necessary for 
the episomal replication, and the expression of late 
genes occurs in the keratinocytes differentiated in the 
upper layers, where the assembly of the viral capsids 
take place, leading to the formation of virions (4). The 
L1 protein is expressed after the L2 protein in the viral 
replication cycle; it is commonly used as an epitope in 
immunohistochemistry (IHC), whereas the L2 protein 
interacts with the E2 protein, facilitating the transport 
of the L1 protein to the nucleus (9).
The objectives of this study are to assess the efficacy of 
Toki’s criteria in identifying through IHC the presence 
of HPV L1 protein in oral mucosal lesions by HPV and 
to determine the clinical and histopathologic variables 
that optimize such identification.
Material and Methods
This is a retrospective and descriptive study of 277 bi-
opsies fixed in 4% formaldehyde buffer, embedded in 
paraffin, preserved at ambient temperature, and previ-
ously diagnosed through histopathologic study as le-
sions by HPV over a period of 22 years (1990-2012). Le-
sions with diagnosis of multifocal epithelial hyperplasia 
(MEH), verruca vulgaris, and condyloma acuminatum, 
which are considered as lesions by HPV (10,11) were 
included in the study, while 99/376 lesions under ineffi-
cient fixation conditions, not fixed in 4% formaldehyde 
buffer, with insufficient material or those without con-
clusive characteristic of lesion by HPV were excluded.
The diagnoses were established with the use of clini-
cal and morphologic criteria. Unique or multiple, small, 
white or pink papular lesions featuring sessile eleva-
tions which may show finger-like projections of strati-
fied squamous epithelium with wide variations in the 
thickness of the keratin layer, usually parakeratinized 
and koilocytosis microscopically (10,11).
The clinical characteristics were obtained from the his-
topathologic applications of patients, and the morpho-
logic data were gathered from the observation of cuts on 
slides with the use of an Olympus optical microscope. 
To determine the presence of HPV L1, tissues were 
stained by IHC.
Forty-nine independent variables consisting of 15 clini-
cal and 34 histopathologic characteristics categorized 
as structural or cellular variables were evaluated. 
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- Clinical variables: Age and gender of the patient, and 
location, number, contour, base, surface, consistency, 
color, type, edge, mobility, pain, diameter, and evolu-
tion of lesions.
- Structural variables: The presence of papillomatosis, 
pseudoepitheliomatous hyperplasia, acanthosis, and a 
granular layer (light, moderate, or prominent); the pres-
ence and intensity of hyperparakeratosis, hyperorthok-
eratosis, or both keratins (considering only the intensity 
of the hyperkeratosis presented); epithelial hyperplasia, 
inflammatory infiltrate, and basal cell hyperplasia; and 
the presence, intensity, and disposition of both intracel-
lular and extracellular edema were evaluated.
- Cellular variables: The presence of dyskeratosis, pino-
cytosis, keratin pearls, and pleomorphism; the presence 
and number per field of cells with degenerative changes 
in their nucleus, binucleated cells, and mitosis; and the 
presence, intensity, disposition, and layer of the koilo-
cytosis were evaluated. 
The intensity of the histologic characteristics was reg-
istered as light, moderate, or severe, and the disposition 
as isolated, focal, or generalized; the cellular changes 
and mitosis were counted by examining all fields.
- Toki’s criteria: Acanthosis, “1”; dyskeratosis, “1”; basi-
lar hyperplasia, “1”; koilocytosis, “4”; bi- or multinucle-
ated cells, “2”; and papillomatosis, “1” (5).
- Immunohistochemistry: Each of the lesions was cut 
to 10µm for IHC staining for HPV; monoclonal mouse 
anti-human papillomavirus (SB24) detects the epitope 
L1. Deparaffinized sections were immersed in absolute 
methanol containing 0.03% (v/v) H2O2 at room tem-
perature to block endogenous peroxidase activity. After 
washing with phosphate-buffered saline (1x PBS, pH 
7.4), the sections were immersed in 0.01M citrate buffer 
(pH 6.0) and heated in a pressure cooker for 15 minutes. 
The sections were incubated in 2% (w/v) bovine serum 
albumin in 1x PBS for 15 minutes at room temperature 
to block nonspecific reactions.
Appropriately diluted HPV antibody (1:100) was applied 
to each section for 30 minutes at room temperature. Af-
ter washing with 1x PBS, the sections were incubated 
with IgM biotinylated goat anti-rabbit (H+L) antibody 
(1:200, Vector Laboratories Inc.) for 10 minutes at room 
temperature and then washed with 1x PBS. Appropri-
ately diluted streptavidin-peroxidase (1:200, Gibco-
BRL, Grand Island, NY, USA) was applied to each 
section for 10 minutes. Then the sections were again 
washed with 1x PBS, immersed for 3 minutes in 0.05% 
3,3’-diaminobenzidine tetrahydrochloride in 0.05M 
Tris-HCl buffer (pH 7.6) containing 0.01% (v/v) H2O2 
(DAB), and counterstained with Mayer s´ hematoxylin. 
Lesions with reaction intensity, light, moderate or se-
vere with a disposition isolated, focal or generalized in 
the cell nuclei of the spinous layer were considered posi-
tive to HPV L1.
- Statistical analysis: The values of the lesions accord-
ing to Toki’s criteria, the clinical and morphologic char-
acteristics, and the positivity for L1 were registered in 
a data base in the SPSS 20 software (IBM, NY, USA). 
To evaluate the effectiveness of Toki’s criteria in the 
diagnosis of HPV L1 through IHC, tests of sensitivity, 
specificity, positive predictive value (PPV), and nega-
tive predictive value (NPV) with the use of Bayes’ theo-
rem were developed. The association and concordance 
between the diagnosis of HPV using Toki’s criteria and 
the identification of the L1 protein by IHC were calcu-
lated by the “chi2” and kappa coefficients, considering 
the valuation of Landis and Koch (12). Two logistic re-
gression analyses were done, one to determine which 
Toki’s criteria are useful for the diagnosis of HPV L1 
in the mouth and another to determine the clinical and 
histopathologic criteria that optimize such diagnosis. 
In the first regression analysis, the presence of HPV L1 
as determined by IHC was considered as the dependent 
variable and Toki’s criteria as independent variables; in 
the second, all the clinical and histopathologic variables 
were evaluated. The categorical variables were trans-
formed into dummy variables in each case, the refer-
ence categories were chosen, and the method used was 
“Enter”. The adjustment of the models was assessed by 
the Hosmer-Lemeshow test and the Nagelkerke’s co-
efficient of determination. The statistically significant 
coefficients (p≤0.05), odds ratio (OR), and confidence 
intervals at 95% were obtained, and receiver operating 
characteristic (ROC) curves were constructed.
Results
During the 22-year period considered, 5,037 studies 
were done in the laboratory, and 277 cases were di-
agnosed as lesions by HPV in the mouth, presenting a 
prevalence of 5.49%. 
The relation between the age range of patients and their 
gender are show in table 1, while the main clinic char-





0-10 20 20 40 
11-20 34 9 43 
21-30 23 9 32 
31-40 32 11 43 
41-50 33 15 48 
51-60 29 10 39 
61-70 16 5 21 
71-80 10 1 11 
Total 197 80 277 
Table 1. Relation between the age range and gender 
of patients.
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habits as smoking and drinking are included in the his-
topathologic applications of patients, often they are not 
reported by clinicians, therefore they could not be as-
sessed in this study.
- Evaluation of Toki’s criteria for the diagnosis of le-
sions by HPV in the mouth through the identification 
of L1 by IHC.
The 96.4% (267 of 277) of lesions had scores great-
er than or equal to 6 when Toki’s criteria were used, 
whereas only 28.5% (79 of 277) were found to be posi-
tive for L1 by IHC. When compared with the IHC test to 
identify HPV L1, the Toki’s criteria showed a sensitivity 
of 93.67%, a specificity of 2.53%, a PPV of 6.99%, and 
a NPV of 46.55%. Neither a significant association (chi2 
p=0.155) nor a statistical concordance (kappa coeffi-
cient p=0.125) was found between Toki’s criteria and 
the IHC test for L1.
The logistic regression model developed to identify 
which of the 6 Toki’s criteria are useful in the diagnosis 
of L1 by IHC correctly classified 71.8% of the lesions 
positive for HPV L1, and showed a Hosmer-Lemeshow 
adjustment of p=0.614 and a Nagelkerke’s coefficient of 
determination of 6.8%. Table 3 shows the Toki’s crite-
ria that enable the diagnosis of HPV by IHC using the 
epitope L1. The koilocytosis did not show statistical 
significance but was retained because it supported the 
adjustment of the model. The ROC curve for the Toki’s 
criteria shows that they have regular diagnostic value, 
with an area under the curve (AUC) of 0.632 (p=0.001). 
Nevertheless, the cutoff for a sensitivity of 87.3% shows 
a specificity of 39.8% and a probability of false positives 
of 60.2% when Toki’s criteria are used in the diagnosis 
of HPV lesions in the mouth where there is L1 expression.
- Evaluation of clinical and histopathologic variables for 
the diagnosis of lesions by HPV in the mouth through 
the identification of L1 by IHC.
The logistic regression model developed correctly clas-
sified 85.2% of the lesions positive for HPV L1 infec-
tion, and showed a Hosmer-Lemeshow adjustment of 
p=0.696 and a Nagelkerke’s coefficient of determination 
of 60.2%. The final model included 20 variables, namely, 
6 clinical, 10 structural, and 4 cellular variables, which 
improved its adjustment: The clinical variables were 
age of patient, and number, contour, base, surface, and 
location of the lesions. The structural variables included 
hyperorthokeratosis, pseudoepitheliomatous hyperpla-
sia, papillomatosis, and granular layer; intensity of the 
epithelial hyperplasia, hyperkeratosis, and extracellular 
edema; presence and intensity of the inflammatory in-
filtrate; and disposition of the intracellular edema. The 
cellular variables were presence of pinocytosis, pres-
ence and number of cells with degenerative changes in 
their nucleus (1 to 4 per field, up to 5 per field, and more 
than 5 per field), and layer of the koilocytosis.
Nevertheless, only 5 of these variables presented a lev-
el of significance of p≤0.05. These included age, with 
patients older of 35±20.2 years having decreased prob-
ability of infection by HPV associated with the expres-
sion of L1 by IHC; presence of multiple lesions, hyper-
orthokeratosis, and focal intracellular edema, which 
increase the risk of infection; and the presence of cells 
with degenerative changes in their nucleus, which is 
associated with the infection in general but showed no 
relevant data in the categories (Table 4).




















?=0.81±0.45cm Sessil 201 
Table 2. Main clinic characteristics of lesions reported by clinicians.
*This category includes both labial and vestibular mucosas.
**The pink color was used to categorize the lesions of similar color to the adjacent mucosa.
Variables ? OR 95% C.I. for OR p Interpretation 
Koilocytosis -1.435 0.238 0.049-1.163 0.07 B 
Dyskeratosis 0.665 1.945 1.137-3.328 0.01 A 
Papillomatosis 0.573 1.774 1.006-3.128 0.04 A 
Table 3. Logistic regression of Toki’s criteria.
A. It increases the probability of presenting an infection by HPV with the expression of L1 
by IHC.
B. It does not show statistical significance but improves the adjustment of the regression 
model.
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The rest of the variables presented significance levels of 
p>0.05 but were kept in the model to improve its adjust-
ment (data not shown). The ROC curve for the clini-
cal and histopathologic variables shows that they have 
a very good diagnostic value (AUC=0.912, p<0.001). 
The cutoff for a sensitivity of 81% shows a specificity of 
85.9% and a probability of false positives of 14.1% when 
these criteria are used in the diagnosis of HPV lesions in 
the mouth where there is L1 expression.
Discussion
The prevalence of OC has increased in the last decade, and 
because HPV is the most important biological factor for 
the disease, the proper diagnosis of HPV is crucial (13).
Toki’s criteria are used for the diagnosis of cervical 
HPV, and due to the simplicity of the system, its ap-
plication has been extended to the field of dentistry (14). 
However, the results of this study imply that its use may 
be inadequate in oral lesions. The percentages of sensi-
tivity, specificity, and PPV presented by Toki’s criteria 
suggest a high probability of false positives when used 
in the diagnosis of lesions by HPV in the mouth associ-
ated with the expression of L1 by IHC.
HPV in the mouth sometimes does not behave as theo-
retically expected, and the HPVs 16 and 18, prevalent 
in potentially malignant oral lesions, typically show a 
low viral load and rarely integrate into the cell genome 
(15,16). In fact, the viral genome in the lesions of oral 
mucosa is generally found in its episomal form, even in 
OC, where the tests of integration of the viral DNA are 
usually negative, this suggests that the model for cervi-
cal cancer is inapplicable to oral tumors (16).
Due to the low number of viral copies that have been 
found in carcinomas and high-risk lesions, the “hit and 
run” theory has been developed, which proposes that 
tumors negative for HPV could develop a precursor 
with HPV content without requiring the HPV to remain 
in the malignant state (17).
On the other hand, the IHC tests used for detection of 
HPV usually use the structural protein L1 as epitope; 
however, when the lesions increase in severity, the tran-
scription of L1 and L2 tends to disappear (9,18), which 
can cause false negatives that may be infected by high-
risk virus types. Thus, some authors do not recommend 
IHC as a screening method for the diagnosis of HPV 
due to its low sensitivity (19). However, the problem 
could be the epitope to which the test is directed; anti-
bodies directed to E6 or E7 could avoid this problem in 
infections by high-risk virus types. 
The relatively low levels of detection of L1 by IHC can 
also be attributed to the antiquity of the samples, which 
influences the denaturation of L1; a low concentration 
of antibody used during the technique and the fixation 
and processing of tissues can have an adverse effect on 
the epitope (19).
In this study, we evaluated the effectiveness of IHC tests 
in identifying infections by HPV in the oral mucosa. 
Our results indicate that in people younger than 35±20.2 
years, the expression of the L1 protein is more prob-
able. This implies that in children and people younger 
than 35 years, there is a protective factor that prevents 
the methylation of the genes E1 and E2 in the URR re-
gion, avoiding the action of E6 and E7 and, hence, the 
integration of the viral DNA with the cellular genome, 
or may be that in people older than 35 years, there is a 
risk factor that causes the methylation of the E1 and E2 
genes. Regarding this, Fernandez et al., reported that 
HPV genome does not encode for any DNA methyl-
transferases and thus it is believed that the viral genome 
is methylated by DNA methyltransferases of the human 
host cell (20). Balderas-Loaeza et al., demonstrated the 
methylation of the HPV16 genome near the 3’ end of the 




-0.037 0.964 0.943-0.985 0.001 B 
Number of lesions 
Multiple 1.047 2.848 1.099-7.380 0.03 A 
Unique Reference category 
Hyperorthoke-
ratosis
Present 2.513 12.35 1.513-100.773 0.01 A 
Absent Reference category 
Disposition of 
intracellular edema 
General significance 0.01  
Absent 0.684 1.981 0.537-7.309 0.30 B 
Isolated 0.166 1.181 0.161-8.657 0.87 B 
Focal 1.585 4.881 1.800-13.239 0.002 A 
Generalized Reference category 
Number of cells with degenerative changes in their nucleus 0.04 C 
Table 4. Logistic regression of the clinical and histopathologic variables.
A. It increases the probability of presenting an infection by HPV with the expression of L1 by IHC.
B. It decreases the probability of presenting an infection by HPV with the expression of L1 by IHC.
C. The variable shows statistical significance in general but not in the categories.
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L1 ORF and in the URR, which regulates the expression 
of E6 and E7 through E2 (21) and Wilson et al., found 
that the sites of methylation within the viral genome are 
mainly detected at the boundary of the L1/L2 ORFs and 
within the E1 ORF (22). Thereby, HPV becomes subject 
of epigenetic modification (20).
The clinical presence of multiple lesions appears to rep-
resent a less aggressive HPV infection because it is as-
sociated with the expression of L1 and is more common 
in children and those younger than 35 years. An exam-
ple is the MEH that is a lesion by HPV often presented 
as a multiple lesion mainly in children which frequently 
resolves spontaneously (23).
The presence of OC from infections by HPV where inte-
gration of the viral DNA to the host DNA does not exist 
suggests that the expression of E6 and E7 is not neces-
sary for the development of cancer or these proteins can 
be activated without that integration. Concerning this, 
Rautava et al., explain that E6 and E7 of the low-risk 
HPV types can also bind to p53 and pRb respectively. 
In the case of p53 will not lead to its degradation but in 
the case of pRb the binding will have a lower affinity, 
nevertheless may lead to its transformation and it has 
been reported that E7 of the low-risk virus HPV1 can 
bind to pRb with the same affinity as E7 of HPV16 (13). 
The PCR test permits the identification of the presence 
(DNA) or expression of a gene (RNA) (24), whereas the 
IHC allows identifying the expression of a protein (25). 
Although the PCR is a powerful tool that enables the 
identification of the expression of genes, such expres-
sion can be affected by epigenetic alterations at the level 
of gene methylation, histone modification, and miRNA 
action during replication, transcription, and translation 
(26). Thus, their amplification and expression by PCR 
or IHC explains a probable tendency in a patient but do 
not guarantees the evolution or development of a lesion, 
and inconsistencies could be found. For this reason, 
their use should be accompanied by periodic clinical 
and histopathologic observations when a high-risk be-
havior is suspected.
Conclusions
Although Toki’s criteria could be useful in the diagnoses 
of cervical lesions, they are not appropriate for the diag-
nosis of oral mucosal lesions by HPV through IHC.
We found clinical and histopathologic criteria that op-
timize the diagnosis of lesions by HPV in the oral mu-
cosa through the identification of the L1 protein by IHC. 
However, they were few and have to be used prudently.
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